El Granada, California
United States
18
2026-05-07
The entities that hold a legal rights for patent applications filed by inventor Sperinde Jeff:
Jeff Sperinde from El Granada, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients
#2 | 2023-03-02Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients
#3 | 2019-08-22Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
#4 | 2019-02-21Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
#5 | 2018-06-14Methods of determining patient response by measurement of HER-3
#6 | 2017-03-23Methods of Determining Patient Response by Measurement of HER-2 Expression
#7 | 2016-03-03Methods of determining patient response by measurement of HER-3 and P95
#8 | 2015-12-31Methods of producing antibodies specific for p95
#9 | 2014-12-18Methods of Determining Patient Response by Measurement of HER-2 Expression
#10 | 2013-11-28Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
#11 | 2013-03-21HER-3 antibodies and methods of use
#12 | 2012-11-22Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients
#13 | 2011-11-10Detection of Activation of Endothelial Cells as Surrogate Marker for Angiogenesis
#14 | 2010-09-16Methods of Determining Patient Response By Measurement of HER-2 Expression
#15 | 2010-08-19Methods of determining patient response by measurement of Her-3
#16 | 2010-06-10Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
#17 | 2009-07-30Her2 diagnostic methods
#18 | 2006-09-07Detection of activation of endothelial cells as surrogate marker for angiogenesis
152965 ⎘